Product Information
LEVOFLOXACIN 250 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.1115 per EA under NDC 72578009818. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
250 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578009818
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA077652On Market Since
1/10/2022
Price Statistics
The NADAC for LEVOFLOXACIN 250 MG TABLET has been published 203 times since Aug 10, 2022, and over the history we have for it it has declined 34.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1115 per EA |
|---|---|
| All-time high | $0.1701 (Aug 10, 2022) |
| All-time low | $0.0920 (Nov 20, 2024) |
| 52-week high | $0.1203 |
| 52-week low | $0.1027 |
| Median price | $0.1279 |
| Average price | $0.1288 |
| Largest weekly change | -38.1% (Nov 20, 2024) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the levofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LEVOFLOXACIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOFLOXACIN 250 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.1115 per EA (NDC 72578009818), effective Jun 24, 2026.
How has the price of LEVOFLOXACIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOFLOXACIN 250 MG TABLET has declined 34.4%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for LEVOFLOXACIN 250 MG TABLET?
Since Aug 10, 2022, the NADAC for LEVOFLOXACIN 250 MG TABLET has ranged from a low of $0.0920 (Nov 20, 2024) to a high of $0.1701 (Aug 10, 2022), with a median of $0.1279 per EA.
Are there cheaper alternatives to LEVOFLOXACIN 250 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LEVOFLOXACIN 250 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures LEVOFLOXACIN 250 MG TABLET?
LEVOFLOXACIN 250 MG TABLET (NDC 72578009818) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification